The negative regulator of G-protein signalling 4 (Rgs4) plays an important role in synaptic plasticity as well as in many diseases of the nervous system, including schizophrenia, addiction, seizure, pain and neurodegenerative disorders [1–5]. Here, RGS4 is linked to schizophrenia.